S. Cigolari
- Oncology top 1%
- Lung Cancer Research Studies 11
- Cancer Treatment and Pharmacology 10
- Colorectal Cancer Treatments and Studies 6
- Pancreatic and Hepatic Oncology Research 3
- Geriatrics and Gerontology top 2%
-
- Lung Cancer Treatments and Mutations 16
- Lung Cancer Diagnosis and Treatment 6
- Cancer Research top 5%
- Hepatology top 10%
-
- Neuroendocrine Tumor Research Advances 6
-
- Cancer therapeutics and mechanisms 3
S. Cigolari
30 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Oncology 1.8k
- Geriatrics and Gerontology 155
- Pulmonary and Respiratory Medicine 1.3k
- Cancer Research 324
- Hepatology 113
Countries citing papers authored by S. Cigolari
This map shows the geographic impact of S. Cigolari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Cigolari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Cigolari more than expected).
Fields of papers citing papers by S. Cigolari
This network shows the impact of papers produced by S. Cigolari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Cigolari. The network helps show where S. Cigolari may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S. Cigolari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 11 | |
| 2 | 2005 | 181 | |
| 3 | 2005 | 352 | |
| 4 | 2004 | 6 | |
| 5 | 2003 | 19 | |
| 6 | Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study. | 2003 | 8 |
| 7 | 2001 | 103 | |
| 8 | 2000 | 51 | |
| 9 | 2000 | 6 | |
| 10 | 2000 | 27 | |
| 11 | 1999 | 1 | |
| 12 | 1998 | 22 | |
| 13 | 1997 | 77 | |
| 14 | 1997 | 4 | |
| 15 | Oral tramadol and buprenorphine in tumour pain. An Italian multicentre trial. | 1996 | 26 |
| 16 | [Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer]. | 1996 | 7 |
| 17 | Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.breakdown → | 1994 | 677 |
| 18 | 1990 | 2 | |
| 19 | 1989 | 2 | |
| 20 | 1984 | 1 |
About S. Cigolari
S. Cigolari is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 30 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (11 papers), Cancer Treatment and Pharmacology (10 papers), Neuroendocrine Tumor Research Advances (6 papers), Lung Cancer Diagnosis and Treatment (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Cancer therapeutics and mechanisms (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Oncology (1.8k citations), Geriatrics and Gerontology (155 citations) and Pulmonary and Respiratory Medicine (1.3k citations). S. Cigolari has collaborated with scholars based in Italy, France and Malaysia. Frequent co-authors include Jean Louis Pujol, Jean‐Yves Douillard, Thierry Le Chevalier, D. Brisgand, Alain Monnier, P. Lianes, P Chomy, Vittorio Gebbia, A. Riviére and V. Alberola. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, European Journal of Cancer, Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.